Clinical Trial

Lipoprotein a Assessment and Relation to Ca Score in CAD Patients Using MSCT

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate whether serum Lipoprotein(a) \[Lp(a)\] levels are associated with coronary artery calcium (CAC) score measured by multi-slice computed tomography (MSCT) in adults undergoing cardiac risk assessment. The main questions it aims to answer are: * Is there a correlation between elevated Lp(a) levels and higher CAC scores? * Does Lp(a) provide additional predictive value for subclinical atherosclerosis beyond traditional cardiovascular risk factors? Participants will: * Undergo a non-contrast MSCT scan to measure CAC score. * Provide a blood sample for measurement of Lp(a) and routine lipid profile. * Have baseline clinical and demographic data collected, including cardiovascular risk factors.
Trial Details
NCT Number NCT07184034
Lead Sponsor Assiut University
Conditions Coronary Artery Disease (CAD)
Enrollment 150 participants
Start Date 2025-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-19